Breast Cancer Genome Guided Therapy Study (BEAUTY)

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03595592` - Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer	Phase 3
Recruiting	`NCT05383196` - Onvansertib + Paclitaxel In TNBC	Phase 1/Phase 2
Recruiting	`NCT06158217` - Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer
Active, not recruiting	`NCT04448886` - Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC	Phase 2
Completed	`NCT02773784` - Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.
Recruiting	`NCT01509781` - Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study	Phase 3
Completed	`NCT04478669` - Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer
Recruiting	`NCT04553770` - Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	Phase 2
Recruiting	`NCT04677816` - Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients	Phase 2
Terminated	`NCT01934335` - Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer	Phase 2
Completed	`NCT00507611` - Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients	N/A
Completed	`NCT00581750` - Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Completed	`NCT03304171` - Overall Diet Quality and Breast Cancer Risk	N/A
Completed	`NCT03709186` - Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
Terminated	`NCT03361800` - Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC	Early Phase 1
Recruiting	`NCT04648904` - Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer	Early Phase 1
Recruiting	`NCT06328465` - fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases	N/A
Active, not recruiting	`NCT03109522` - Axillary Reverse Mapping (ARM) Technique	N/A
Recruiting	`NCT03987555` - Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Recruiting	`NCT03497702` - Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer	Phase 2

NCT number	NCT02022202
Study type	Observational
Source	Mayo Clinic
Contact
Status	Active, not recruiting
Phase
Start date	February 2013
Completion date	December 14, 2032

Breast Cancer Genome Guided Therapy Study (BEAUTY) — BEAUTY

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms